Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q18032466> ?p ?o }
Showing triples 1 to 28 of
28
with 100 triples per page.
- Q18032466 subject Q18071332.
- Q18032466 abstract "FCM, or FMC in the context of chemotherapy is an acronym for a chemotherapy regimen that is often used in the treatment of indolent B cell non-Hodgkin's lymphomas. In combination with Rituximab this regimen is called R-FCM or R-FMC, or FCM-R, FMC-R. The [R]-FCM regimen contains (R)ituximab - anti-CD20 monoclonal antibody that can kill both normal and malignant CD20-bearing B cells; (F)ludarabine - an antimetabolite; (C)yclophosphamide - an alkylating antineoplastic agent from the oxazafosforine group; (M)itoxantrone - a synthetic antracycline analogue (antraquinone) that can intercalate DNA, thereby preventing cell division. The FCM or R-FCM regimen is also sometimes used in some autoimmune diseases that are inherently sensitive to the use of rituximab, fludarabine, mitoxantrone, and cyclophosphamide alone in monotherapies (e.g., in severe multiple sclerosis flares).".
- Q18032466 wikiPageWikiLink Q101244.
- Q18032466 wikiPageWikiLink Q1046958.
- Q18032466 wikiPageWikiLink Q1138590.
- Q18032466 wikiPageWikiLink Q1483951.
- Q18032466 wikiPageWikiLink Q14906101.
- Q18032466 wikiPageWikiLink Q17056749.
- Q18032466 wikiPageWikiLink Q18071332.
- Q18032466 wikiPageWikiLink Q185916.
- Q18032466 wikiPageWikiLink Q188909.
- Q18032466 wikiPageWikiLink Q188930.
- Q18032466 wikiPageWikiLink Q208414.
- Q18032466 wikiPageWikiLink Q239426.
- Q18032466 wikiPageWikiLink Q408524.
- Q18032466 wikiPageWikiLink Q412323.
- Q18032466 wikiPageWikiLink Q417589.
- Q18032466 wikiPageWikiLink Q422248.
- Q18032466 wikiPageWikiLink Q5090632.
- Q18032466 wikiPageWikiLink Q577994.
- Q18032466 wikiPageWikiLink Q619908.
- Q18032466 wikiPageWikiLink Q7430.
- Q18032466 wikiPageWikiLink Q79460.
- Q18032466 wikiPageWikiLink Q8084905.
- Q18032466 wikiPageWikiLink Q8277.
- Q18032466 wikiPageWikiLink Q974135.
- Q18032466 comment "FCM, or FMC in the context of chemotherapy is an acronym for a chemotherapy regimen that is often used in the treatment of indolent B cell non-Hodgkin's lymphomas. In combination with Rituximab this regimen is called R-FCM or R-FMC, or FCM-R, FMC-R.".
- Q18032466 label "FCM (chemotherapy)".